SARS-CoV-2 variant detection and identification
Effective genomic surveillance of SARS-CoV-2 variants begins with the right tools
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Emerging SARS-CoV-2 variants will require global monitoring to ensure diagnostic tests, vaccines, and other antiviral therapies remain effective. As the virus’ mutations change its transmissibility and/or severity, public health control measures can stay ahead of the curve by analysing a subset of positive COVID-19 patient samples. These genomic surveillance programs include genotyping and sequencing the mutations, which can help characterise known variants and discover novel variants.
How to choose a molecular diagnostics supplier
In this guide, LGC, Biosearch Technologies, provides a streamlined approach to choosing an experienced supplier for your molecular diagnostics components, including:
- Key questions for your internal team to identify supply needs for current R&D and future commercialization
- A process for researching and evaluating potential supply partners
- Tips for managing a strong and dynamic relationship with your supplier
Product Overview
Links
Products Model Information
SARS-CoV-2 Variant ValuPanel™ assays
LGC Diagnostics and Genomics - Rapid Genomics Genotyping SolutionsSARS-CoV-2 Variant ValuPanel™ assays consist of separately delivered probes and primers that are designed for qualitative detection of specific SARS-CoV-2 mutations by genotyping using reverse transcription-polymerase chain reaction (RT-PCR).
